Avantor Bio-Expo Live November 2025: Upstream Bioprocessing

Biologics manufacturing faces increasing complexity in buffer preparation due to variable production demands. Traditional made-in-house (MIH) methods are often insufficient, prompting the need for hybrid strategies that incorporate in-line dilution (ILD), in-line conditioning (ILC), and ready-to-use (RTU) buffers. This presentation introduces a Hybrid Buffer Strategy Assessment Tool that enables facilities to evaluate buffer approaches using multi-criteria analysis.